Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Non-Current Assets (2014 - 2026)

Viking Therapeutics' (VKTX) quarterly Non-Current Assets came in at $4.3 million in Q2 2026, up 419.66% year-over-year from $834000.0 in Q2 2025, and up 13033.33% quarter-over-quarter from $33000.0 in Q1 2026.

Analysis

Viking Therapeutics (VKTX) Non-Current Assets (2014 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Non-Current Assets across 13 years of filings, most recently posting $4.3 million for Q2 2026.

  • In Q2 2026, Non-Current Assets rose 419.66% year-over-year to $4.3 million; the TTM figure through Jun 2026 stood at $5.2 million (up 25.6% YoY), while the FY2025 annual figure was $131000.0, down 88.14% from the prior year.
  • Non-Current Assets came in at $4.3 million for Q2 2026 at Viking Therapeutics, up from $33000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $4.3 million in Q2 2026 to a low of $33000.0 in Q1 2026.
  • Average Non-Current Assets over 5 years is $1.3 million, with a median of $1.3 million recorded in 2023.
  • Year-over-year, Non-Current Assets surged 1011.19% in 2022 and slumped 96.6% in 2026.
  • Over 5 years, Non-Current Assets stood at $1.5 million in 2022, then decreased by 15.04% to $1.3 million in 2023, then slipped by 12.65% to $1.1 million in 2024, then slumped by 88.14% to $131000.0 in 2025, then jumped by 3208.4% to $4.3 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $4.3 million in Q2 2026, $33000.0 in Q1 2026, and $131000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 141.29 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 101.45 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 87.87 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 35.42 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 14.88 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn - 4.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.33 Mn
Mar 31, 2026 33,000.00
Dec 31, 2025 131,000.00
Sep 30, 2025 712,000.00
Jun 30, 2025 834,000.00
Mar 31, 2025 970,000.00
Dec 31, 2024 1.11 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 1.18 Mn
Dec 31, 2023 1.27 Mn
Sep 30, 2023 1.36 Mn
Jun 30, 2023 1.32 Mn
Mar 31, 2023 1.43 Mn
Dec 31, 2022 1.49 Mn
Sep 30, 2022 1.54 Mn
Jun 30, 2022 1.65 Mn
Mar 31, 2022 1.73 Mn
Dec 31, 2021 134,000.00
Sep 30, 2021 189,000.00
API Access

Viking Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY